Stocks to Watch: Palo Alto Networks, SolarEdge, Teladoc Health
By Ben Glickman
Palo Alto Networks reduced its full-year outlook for fiscal 2024 revenue despite fiscal second-quarter results topping expectations. The cybersecurity company now expects revenue of $7.95 billion to $8 billion, compared with previous guidance of $8.15 billion to $8.2 billion. Shares fell 20% to $291.97 in after-hours trading.
SolarEdge Technologies saw higher interest rates and lower power prices continue to dent residential solar demand, with revenue falling 56% in the fourth quarter. The company forecast first-quarter revenue of $175 million to $215 million, which would represent a 77% to 81% drop from a year earlier. Shares fell 12% to $74.49 in after-hours trading.
Teladoc Health late Tuesday forecast a wider-than-expected loss in the first quarter and revenue below analysts' expectations. The telehealth company also forecast $2.64 billion to $2.74 billion in revenue for 2024, below the $2.77 billion forecast by analysts. Shares dropped 17% to $16.99 after hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
February 20, 2024 18:51 ET (23:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
10 Top-Performing Dividend Stocks
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters
-
CVS Earnings: Weak Medicare Advantage Profits Cut Into 2024 Outlook
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry